PHASE 2 KEYNOTE‐667: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT‐LINE CHEMOTHERAPY
Gespeichert in:
| Veröffentlicht in: | Hematological oncology 2023-06, Vol.41 (S2), p.66-67 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 67 |
|---|---|
| container_issue | S2 |
| container_start_page | 66 |
| container_title | Hematological oncology |
| container_volume | 41 |
| creator | Vinti, L. Daw, S. Alvarez, C. Sabado Fagioli, F. Beishuizen, A. Michel, G. Moleti, M. L. Cepelova, M. Thorwarth, A. Rigaud, C. Lopez de Sabando, D. Plaza Landman‐Parker, J. Shen, J. Pillai, P. Marinello, P. Mauz‐Koerholz, C. |
| description | |
| doi_str_mv | 10.1002/hon.3163_31 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3089983248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3089983248</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1453-dfb32b372870f2728abca588bcd2ec7232fdc79ece9899b505a0b4e16a6f3b363</originalsourceid><addsrcrecordid>eNp9kEtOwzAQhi0EEuWx4gKW2IBQwI82D3ZuauoIx46SVChsrCRNBFVpIQEhdhyBC3A5ToKrsmbjkTXfzKf5ATjB6BIjRK4e1qtLil1qKN4BA4yCwMHIDXbBABHPdxChZB8c9P0CIdtD_gB8J4JlHBJ4ywulc_7z-eW63jVMeDxOtYzuZzEbw0jBUERyknIFmZrAQs_UFLLJTOYZvItyAUPJsiwKmYRCT6a3dkAWcSJ0zOBZKOT5lsqkvoOcpbKAKc8Sraw61_Am1Sq3ZhkpbkU81rngKUuKI7DXlsu-Of6rh2B2w_NQOFJPNzKnxsMRdeZtRUlFPeJ7qCW2lFVdjny_quekqT17dTuvvaCpm8APgmqERiWqhg12S7elFXXpITjd7n3u1i9vTf9qFuu3bmWVhiI74lMy9C11saXqbt33XdOa5-7xqew-DEZmk7-x-Zu__C1Nt_T747L5-A81Qiv7bn70F7Wffio</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3089983248</pqid></control><display><type>article</type><title>PHASE 2 KEYNOTE‐667: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT‐LINE CHEMOTHERAPY</title><source>Access via Wiley Online Library</source><creator>Vinti, L. ; Daw, S. ; Alvarez, C. Sabado ; Fagioli, F. ; Beishuizen, A. ; Michel, G. ; Moleti, M. L. ; Cepelova, M. ; Thorwarth, A. ; Rigaud, C. ; Lopez de Sabando, D. Plaza ; Landman‐Parker, J. ; Shen, J. ; Pillai, P. ; Marinello, P. ; Mauz‐Koerholz, C.</creator><creatorcontrib>Vinti, L. ; Daw, S. ; Alvarez, C. Sabado ; Fagioli, F. ; Beishuizen, A. ; Michel, G. ; Moleti, M. L. ; Cepelova, M. ; Thorwarth, A. ; Rigaud, C. ; Lopez de Sabando, D. Plaza ; Landman‐Parker, J. ; Shen, J. ; Pillai, P. ; Marinello, P. ; Mauz‐Koerholz, C.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.3163_31</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Chemotherapy ; Hodgkin's lymphoma ; Lymphoma ; Pembrolizumab ; Young adults</subject><ispartof>Hematological oncology, 2023-06, Vol.41 (S2), p.66-67</ispartof><rights>2023 The Authors. Hematological Oncology published by John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhon.3163_31$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhon.3163_31$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27933,27934,45583,45584</link.rule.ids></links><search><creatorcontrib>Vinti, L.</creatorcontrib><creatorcontrib>Daw, S.</creatorcontrib><creatorcontrib>Alvarez, C. Sabado</creatorcontrib><creatorcontrib>Fagioli, F.</creatorcontrib><creatorcontrib>Beishuizen, A.</creatorcontrib><creatorcontrib>Michel, G.</creatorcontrib><creatorcontrib>Moleti, M. L.</creatorcontrib><creatorcontrib>Cepelova, M.</creatorcontrib><creatorcontrib>Thorwarth, A.</creatorcontrib><creatorcontrib>Rigaud, C.</creatorcontrib><creatorcontrib>Lopez de Sabando, D. Plaza</creatorcontrib><creatorcontrib>Landman‐Parker, J.</creatorcontrib><creatorcontrib>Shen, J.</creatorcontrib><creatorcontrib>Pillai, P.</creatorcontrib><creatorcontrib>Marinello, P.</creatorcontrib><creatorcontrib>Mauz‐Koerholz, C.</creatorcontrib><title>PHASE 2 KEYNOTE‐667: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT‐LINE CHEMOTHERAPY</title><title>Hematological oncology</title><subject>Chemotherapy</subject><subject>Hodgkin's lymphoma</subject><subject>Lymphoma</subject><subject>Pembrolizumab</subject><subject>Young adults</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kEtOwzAQhi0EEuWx4gKW2IBQwI82D3ZuauoIx46SVChsrCRNBFVpIQEhdhyBC3A5ToKrsmbjkTXfzKf5ATjB6BIjRK4e1qtLil1qKN4BA4yCwMHIDXbBABHPdxChZB8c9P0CIdtD_gB8J4JlHBJ4ywulc_7z-eW63jVMeDxOtYzuZzEbw0jBUERyknIFmZrAQs_UFLLJTOYZvItyAUPJsiwKmYRCT6a3dkAWcSJ0zOBZKOT5lsqkvoOcpbKAKc8Sraw61_Am1Sq3ZhkpbkU81rngKUuKI7DXlsu-Of6rh2B2w_NQOFJPNzKnxsMRdeZtRUlFPeJ7qCW2lFVdjny_quekqT17dTuvvaCpm8APgmqERiWqhg12S7elFXXpITjd7n3u1i9vTf9qFuu3bmWVhiI74lMy9C11saXqbt33XdOa5-7xqew-DEZmk7-x-Zu__C1Nt_T747L5-A81Qiv7bn70F7Wffio</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Vinti, L.</creator><creator>Daw, S.</creator><creator>Alvarez, C. Sabado</creator><creator>Fagioli, F.</creator><creator>Beishuizen, A.</creator><creator>Michel, G.</creator><creator>Moleti, M. L.</creator><creator>Cepelova, M.</creator><creator>Thorwarth, A.</creator><creator>Rigaud, C.</creator><creator>Lopez de Sabando, D. Plaza</creator><creator>Landman‐Parker, J.</creator><creator>Shen, J.</creator><creator>Pillai, P.</creator><creator>Marinello, P.</creator><creator>Mauz‐Koerholz, C.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>202306</creationdate><title>PHASE 2 KEYNOTE‐667: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT‐LINE CHEMOTHERAPY</title><author>Vinti, L. ; Daw, S. ; Alvarez, C. Sabado ; Fagioli, F. ; Beishuizen, A. ; Michel, G. ; Moleti, M. L. ; Cepelova, M. ; Thorwarth, A. ; Rigaud, C. ; Lopez de Sabando, D. Plaza ; Landman‐Parker, J. ; Shen, J. ; Pillai, P. ; Marinello, P. ; Mauz‐Koerholz, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1453-dfb32b372870f2728abca588bcd2ec7232fdc79ece9899b505a0b4e16a6f3b363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Chemotherapy</topic><topic>Hodgkin's lymphoma</topic><topic>Lymphoma</topic><topic>Pembrolizumab</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vinti, L.</creatorcontrib><creatorcontrib>Daw, S.</creatorcontrib><creatorcontrib>Alvarez, C. Sabado</creatorcontrib><creatorcontrib>Fagioli, F.</creatorcontrib><creatorcontrib>Beishuizen, A.</creatorcontrib><creatorcontrib>Michel, G.</creatorcontrib><creatorcontrib>Moleti, M. L.</creatorcontrib><creatorcontrib>Cepelova, M.</creatorcontrib><creatorcontrib>Thorwarth, A.</creatorcontrib><creatorcontrib>Rigaud, C.</creatorcontrib><creatorcontrib>Lopez de Sabando, D. Plaza</creatorcontrib><creatorcontrib>Landman‐Parker, J.</creatorcontrib><creatorcontrib>Shen, J.</creatorcontrib><creatorcontrib>Pillai, P.</creatorcontrib><creatorcontrib>Marinello, P.</creatorcontrib><creatorcontrib>Mauz‐Koerholz, C.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vinti, L.</au><au>Daw, S.</au><au>Alvarez, C. Sabado</au><au>Fagioli, F.</au><au>Beishuizen, A.</au><au>Michel, G.</au><au>Moleti, M. L.</au><au>Cepelova, M.</au><au>Thorwarth, A.</au><au>Rigaud, C.</au><au>Lopez de Sabando, D. Plaza</au><au>Landman‐Parker, J.</au><au>Shen, J.</au><au>Pillai, P.</au><au>Marinello, P.</au><au>Mauz‐Koerholz, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PHASE 2 KEYNOTE‐667: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT‐LINE CHEMOTHERAPY</atitle><jtitle>Hematological oncology</jtitle><date>2023-06</date><risdate>2023</risdate><volume>41</volume><issue>S2</issue><spage>66</spage><epage>67</epage><pages>66-67</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.3163_31</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-0232 |
| ispartof | Hematological oncology, 2023-06, Vol.41 (S2), p.66-67 |
| issn | 0278-0232 1099-1069 |
| language | eng |
| recordid | cdi_proquest_journals_3089983248 |
| source | Access via Wiley Online Library |
| subjects | Chemotherapy Hodgkin's lymphoma Lymphoma Pembrolizumab Young adults |
| title | PHASE 2 KEYNOTE‐667: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT‐LINE CHEMOTHERAPY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-29T23%3A50%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PHASE%202%20KEYNOTE%E2%80%90667:%20PEMBROLIZUMAB%20IN%20CHILDREN%20AND%20YOUNG%20ADULTS%20WITH%20CLASSICAL%20HODGKIN%20LYMPHOMA%20(CHL)%20WITH%20SLOW%20EARLY%20RESPONSE%20TO%20FRONT%E2%80%90LINE%20CHEMOTHERAPY&rft.jtitle=Hematological%20oncology&rft.au=Vinti,%20L.&rft.date=2023-06&rft.volume=41&rft.issue=S2&rft.spage=66&rft.epage=67&rft.pages=66-67&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.3163_31&rft_dat=%3Cproquest_cross%3E3089983248%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3089983248&rft_id=info:pmid/&rfr_iscdi=true |